Digitalis Use and the Risk of Breast Cancer: A Systematic Review and Meta-Analysis (Q39107268)

9 September 2017

0 references

Digitalis Use and the Risk of Breast Cancer: A Systematic Review and Meta-Analysis (English)

1 reference

9 September 2017

1 reference

Chen Zhang

1

1 reference

9 September 2017

Shao-Hua Xie

2

1 reference

9 September 2017

Bingfei Xu

3

1 reference

9 September 2017

Shi Lu

4

1 reference

9 September 2017

Pian Liu

5

1 reference

9 September 2017

publication date

28 January 2017

1 reference

9 September 2017

1 reference

9 September 2017

volume

40

1 reference

9 September 2017

issue

4

1 reference

9 September 2017

page(s)

285-292

1 reference

Mechanism of interaction of digitalis with estradiol binding sites in rat uteri

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0484-Z

Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0484-Z

Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0484-Z

Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0484-Z

Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0484-Z

Digoxin use and the risk of breast cancer in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0484-Z

Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0484-Z

Digoxin use and risk of invasive breast cancer: evidence from the Nurses' Health Study and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0484-Z

Digitalis and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0484-Z

Digitoxin medication and cancer; case control and internal dose-response studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0484-Z

Cohort study of risk factors for breast cancer in post menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0484-Z

Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0484-Z

Cardiac glycosides and the risk of breast cancer in women with chronic heart failure and supraventricular arrhythmia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0484-Z

Nonestrogenic drugs and breast cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28130772

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Breast cancer and use of rauwolfia and other antihypertensive agents in hypertensive patients: a nationwide case-control study in Finland

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28130772

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Na+/K+ ATPase inhibitors in cancer.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28130772

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S40264-016-0484-Z

1 reference

9 September 2017

1 reference